Search results
Showing 1 to 14 of 14 results for thyroid nodules
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (HTG416)
Evidence-based recommendations on ultrasound-guided percutaneous radiofrequency ablation for treating benign thyroid nodules in adults. This involves using heat energy to destroy tissue in the nodules.
High-intensity focused ultrasound for symptomatic benign thyroid nodules (HTG504)
Evidence-based recommendations on high-intensity focused ultrasound for symptomatic benign thyroid nodules in adults. This involves using heat made by high-frequency sound waves to destroy the nodule.
View recommendations for HTG504Show all sections
This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (HTG646)
Evidence-based recommendations on percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules. This involves using microwaves from a wire inserted into the nodule to heat and destroy it (ablation).
View recommendations for HTG646Show all sections
Percutaneous Laser Ablation (PLA) for benign thyroid nodules
Topic prioritisation
This guideline covers diagnosis and management of thyroid cancer in people aged 16 and over. It aims to reduce variation in practice and increase the quality of care and survival for people with thyroid cancer.
research should report details of patient selection, nodule size and position, and whether the nodule is cystic. Any...
for benign thyroid nodules? Any explanatory notes(if applicable) Source guidance details Comes from guidance Thyroid...
Evidence-based recommendations on minimally invasive video-assisted thyroidectomy. This involves inserting instruments through a small cut (keyhole surgery) to remove part or all of the gland.
This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that may suggest cancer.
Show all sections
Sections for NG12
Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (CG104)
This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (IPG562)
We have moved interventional procedures guidance 562 to become HealthTech guidance 416. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
High-intensity focused ultrasound for symptomatic benign thyroid nodules (IPG643)
We have moved interventional procedures guidance 643 to become HealthTech guidance 504. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (IPG743)
We have moved interventional procedures guidance 743 to become HealthTech guidance 646. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.